{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:33:50Z","timestamp":1772019230663,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Adenosine has been tested in several randomized controlled trials (RCTs) to minimize the incidence of coronary microvascular obstruction (CMVO). The aim of this study was to pool all the RCTs comparing intracoronary or intravenous adenosine versus placebo in patients with acute coronary syndrome (ACS) undergoing myocardial revascularization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>PubMed and Scopus electronic databases were scanned for eligible studies up to 5th June 2022. A total of 26 RCTs with 5843 patients were included. Efficacy endpoints were major adverse cardiac events (MACE), all-cause death, non-fatal myocardial infarction, and heart failure. Atrioventricular blocks and ventricular fibrillation\/sustained ventricular tachycardia (VF\/SVT) were the safety endpoints. Myocardial blush grade, thrombolysis in myocardial infarction (TIMI) flow grade, left ventricular ejection fraction (LVEF), infarct size, and ST-segment resolution were also assessed. Adenosine administration was not associated with any clinical benefit in terms of MACE, all-cause death, non-fatal myocardial infarction, and heart failure. However, adenosine was associated with an increased rate of advanced atrioventricular blocks and of VF\/SVT in studies with total mean ischaemic time\u00a0&amp;gt;3\u00a0h, compared to placebo. Remarkably, among patients undergoing percutaneous coronary intervention, adenosine was associated with reduced myocardial blush grade 0\u20131 and TIMI flow grade 0\u20132, compared to placebo. Furthermore, adenosine did not show favourable effects on LVEF and infarct size.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Adenosine infusion, as adjunctive therapy in ACS, was associated with an increased risk of advanced atrioventricular blocks and increased rates of adenosine-triggered ventricular arrhythmias in patients with long ischaemic time, without providing any clinical benefit compared to placebo.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvac069","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:16:41Z","timestamp":1670717801000},"page":"173-182","source":"Crossref","is-referenced-by-count":13,"title":["Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"9","author":[{"given":"Renzo","family":"Laborante","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Bianchini","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9097-5287","authenticated-orcid":false,"given":"Attilio","family":"Restivo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ciliberti","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"},{"name":"Department of Cardiology, Maria Cecilia Hospital, GVM Care & Research , Cotignola (RA), Cotignola 48033, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Vergallo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Rodolico","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Zito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Princi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Maria","family":"Leone","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Aurigemma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Romagnoli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco Antonio","family":"Montone","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Burzotta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"},{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Trani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"},{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome 00168 , Italy"},{"name":"Department of Cardiovascular and Thoracic Sciences , Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3774-8330","authenticated-orcid":false,"given":"Domenico","family":"D'Amario","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine , Universit\u00e0 del Piemonte Orientale, Padiglione G, L.go Bellini, Novara, NO, 28100 , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"issue":"2","key":"2023020208424658500_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"2023020208424658500_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"47","key":"2023020208424658500_bib3","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"issue":"10","key":"2023020208424658500_bib4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCRESAHA.116.308640","article-title":"The coronary circulation as a target of cardioprotection","volume":"118","author":"Heusch","year":"2016","journal-title":"Circ Res"},{"issue":"4","key":"2023020208424658500_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41569-021-00632-2","article-title":"A fresh look at coronary microembolization","volume":"19","author":"Kleinbongard","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"2023020208424658500_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","article-title":"Optimized treatment of ST-elevation myocardial infarction","volume":"125","author":"Niccoli","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"2023020208424658500_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-009-0074-7","article-title":"Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve","volume":"105","author":"Heusch","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"2023020208424658500_bib8","doi-asserted-by":"crossref","first-page":"856747","DOI":"10.3389\/fphar.2022.856747","article-title":"Adenosine in acute myocardial infarction-associated reperfusion injury: does it still have a role?","volume":"13","author":"De Marco","year":"2022","journal-title":"Front Pharmacol"},{"issue":"32","key":"2023020208424658500_bib9","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1097\/MD.0000000000001279","article-title":"Efficacy of adenosine in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a PRISMA-compliant meta-analysis","volume":"94","author":"Gao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2023020208424658500_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2015.09.005","article-title":"Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials","volume":"202","author":"Bulluck","year":"2016","journal-title":"Int J Cardiol"},{"key":"2023020208424658500_bib11","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijcard.2015.11.086","article-title":"Impact of intracoronary adenosine administration during primary PCI: a meta-analysis","volume":"203","author":"Polimeni","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"2023020208424658500_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2023020208424658500_bib13","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"2023020208424658500_bib14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0735-1097(99)00418-0","article-title":"Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial","volume":"34","author":"Mahaffey","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2023020208424658500_bib15","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.101.18.2154","article-title":"Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction","volume":"101","author":"Marzilli","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"2023020208424658500_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-003-0564-8","article-title":"Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study","volume":"59","author":"Quintana","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"2023020208424658500_bib17","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)","volume":"45","author":"Ross","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2023020208424658500_bib18","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.amjcard.2005.06.090","article-title":"Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting","volume":"96","author":"Micari","year":"2005","journal-title":"Am J Cardiol"},{"issue":"5","key":"2023020208424658500_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ahj.2005.07.012","article-title":"Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine","volume":"150","author":"Petronio","year":"2005","journal-title":"Am Heart J"},{"issue":"9","key":"2023020208424658500_bib20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/hrt.2005.075077","article-title":"Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes","volume":"92","author":"Vijayalakshmi","year":"2006","journal-title":"Heart"},{"issue":"3\u20134","key":"2023020208424658500_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1139\/Y07-013","article-title":"Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow\/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning","volume":"85","author":"Parikh","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"2023020208424658500_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ccd.21334","article-title":"High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study","volume":"71","author":"Stoel","year":"2008","journal-title":"Catheter Cardiovasc. Interv."},{"issue":"3","key":"2023020208424658500_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00029330-200802010-00001","article-title":"Intracoronary adenosine improves myocardial perfusion in late reperfused myocardial infarction","volume":"121","author":"Tian","year":"2008","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2023020208424658500_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCINTERVENTIONS.109.858977.109.858977","article-title":"Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial","volume":"2","author":"Fokkema","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"2023020208424658500_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/eurheartj\/ehq492","article-title":"High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction","volume":"32","author":"Desmet","year":"2011","journal-title":"Eur Heart J"},{"issue":"3","key":"2023020208424658500_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1681.2012.05668.x","article-title":"Beneficial effect of adenosine on myocardial perfusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarction","volume":"39","author":"Wang","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"10","key":"2023020208424658500_bib27","first-page":"1713","article-title":"Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction","volume":"125","author":"Zhang","year":"2012","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"2023020208424658500_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000346876","article-title":"Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury\u2014clinical outcome and 1-year follow-up","volume":"124","author":"Grygier","year":"2013","journal-title":"Cardiology"},{"issue":"6","key":"2023020208424658500_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jcin.2013.02.009","article-title":"Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)","volume":"6","author":"Niccoli","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"2023020208424658500_bib30","first-page":"839","article-title":"Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction","volume":"41","author":"Tong","year":"2013","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"2","key":"2023020208424658500_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jsha.2013.03.096","article-title":"Intracoronary adenosine as an adjunct to primary coronary intervention in acute myocardial infarction","volume":"25","author":"Darahim","year":"2013","journal-title":"J Saudi Heart Assoc"},{"issue":"3","key":"2023020208424658500_bib32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijcard.2014.09.203","article-title":"Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial","volume":"177","author":"Garcia-Dorado","year":"2014","journal-title":"Int J Cardiol"},{"issue":"5","key":"2023020208424658500_bib33","first-page":"389","article-title":"Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction","volume":"62","author":"Faruk Akturk","year":"2014","journal-title":"Minerva Cardioangiol"},{"issue":"24","key":"2023020208424658500_bib34","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","article-title":"Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial","volume":"37","author":"Nazir","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"2023020208424658500_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10557-015-6631-4","article-title":"Impact of intracoronary adenosine on myonecrosis in patients with unstable angina pectoris undergoing percutaneous coronary intervention","volume":"29","author":"Kizilirmak","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"2023020208424658500_bib36","first-page":"640","article-title":"Evaluation of short- and long-term efficacy of combined intracoronary administration of high-dose adenosine and tirofiban during primary percutaneous coronary intervention","volume":"32","author":"Li","year":"2016","journal-title":"Acta Cardiol Sin"},{"issue":"6","key":"2023020208424658500_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCA.0000000000000863","article-title":"Randomized trial of intracoronary adenosine as adjunctive therapy for prevention of the no-reflow phenomenon","volume":"31","author":"Naghshtabrizi","year":"2020","journal-title":"Coron Artery Dis."},{"issue":"1","key":"2023020208424658500_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14017431.2022.2035807","article-title":"Administration of intracoronary adenosine before stenting for the prevention of no-reflow in patients with ST-elevation myocardial infarction","volume":"56","author":"Sadeghian","year":"2022","journal-title":"Scand Cardiovasc J"},{"key":"2023020208424658500_bib39","article-title":"Effect of adenosine on ischemia-reperfusion injury during percutaneous coronary intervention","author":"JI","year":"2007","journal-title":"Chinese J Tissue Eng Res"},{"issue":"16","key":"2023020208424658500_bib40","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMra065985","article-title":"Time to treatment in primary percutaneous coronary intervention","volume":"357","author":"Nallamothu","year":"2007","journal-title":"N Engl J Med"},{"issue":"13","key":"2023020208424658500_bib41","doi-asserted-by":"crossref","first-page":"e019899","DOI":"10.1161\/JAHA.120.019899","article-title":"Adenosine-induced coronary steal is observed in patients presenting with ST-segment-elevation myocardial infarction","volume":"10","author":"Aetesam-Ur-Rahman","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2023020208424658500_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.235713","article-title":"Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation","volume":"108","author":"Kleinbongard","year":"2011","journal-title":"Circ Res"},{"issue":"11","key":"2023020208424658500_bib43","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2004.02.031","article-title":"Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion","volume":"93","author":"Giugliano","year":"2004","journal-title":"Am J Cardiol"},{"issue":"15","key":"2023020208424658500_bib44","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jcin.2015.08.033","article-title":"Limitation of infarct size and no-reflow by intracoronary adenosine depends critically on dose and duration","volume":"8","author":"Yetgin","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"2023020208424658500_bib45","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/eurheartj\/ehq299","article-title":"No-reflow: again prevention is better than treatment","volume":"31","author":"Niccoli","year":"2010","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvac069\/48411261\/pvac069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/9\/2\/173\/49043679\/pvac069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/9\/2\/173\/49043679\/pvac069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T09:02:24Z","timestamp":1675328544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/9\/2\/173\/6887276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,12,10]]},"published-print":{"date-parts":[[2023,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvac069","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3]]},"published":{"date-parts":[[2022,12,10]]}}}